These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 2510749)

  • 21. DBT: a partial D phenotype associated with the low-incidence antigen Rh32.
    Wallace M; Lomas-Francis C; Beckers E; Bruce M; Campbell G; Chatfield S; Nagao N; Okubo Y; Opalka A; Overbeeke M; Scott M; Voak D
    Transfus Med; 1997 Sep; 7(3):233-8. PubMed ID: 9316225
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Murine monoclonal antibodies associated with Rh17, Rh29, and Rh46 antigens.
    Rouger P; Edelman L
    Transfusion; 1988; 28(1):52-5. PubMed ID: 2448930
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Change in Rh phenotype.
    Kumar S
    J Indian Med Assoc; 1997 Jun; 95(6):199. PubMed ID: 9420409
    [No Abstract]   [Full Text] [Related]  

  • 24. [Foetomaternal erythrocyte incompatibilities: from immunohaematologic surveillance of pregnant women to haemolytic disease of the newborn].
    Miquel E; Cavelier B; Bonneau JC; Rouger P
    Transfus Clin Biol; 2005 Feb; 12(1):45-55. PubMed ID: 15814293
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Partial D, weak D types, and novel RHD alleles among 33,864 multiethnic patients: implications for anti-D alloimmunization and prevention.
    Denomme GA; Wagner FF; Fernandes BJ; Li W; Flegel WA
    Transfusion; 2005 Oct; 45(10):1554-60. PubMed ID: 16181204
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Do we need to be more concerned about weak D antigens?
    Garratty G
    Transfusion; 2005 Oct; 45(10):1547-51. PubMed ID: 16181202
    [No Abstract]   [Full Text] [Related]  

  • 27. First report from India of haemolytic disease of newborn by anti-c and anti-E in Rh (D) positive mothers.
    Thakral B; Agrawal SK; Dhawan HK; Saluja K; Dutta S; Marwaha N
    Hematology; 2007 Oct; 12(5):377-80. PubMed ID: 17852437
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Major histocompatibility complex markers and red cell antibodies to the Rh (D) antigen. Absence of association.
    Kruskall MS; Yunis EJ; Watson A; Awdeh Z; Alper CA
    Transfusion; 1990 Jan; 30(1):15-9. PubMed ID: 2104997
    [TBL] [Abstract][Full Text] [Related]  

  • 29. On a much higher than reported incidence of anti-c in R1R1 patients with anti-E.
    Judd WJ; Dake LR; Davenport RD
    Immunohematology; 2005; 21(3):94-6. PubMed ID: 16178665
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Contribution of red blood group genotyping for recipients in immune-hematology through three years of activity at the EFS Alpes-Méditerranée].
    Silvy M; Filosa L; Chiaroni J; Bailly P
    Transfus Clin Biol; 2014 Dec; 21(6):289-95. PubMed ID: 25443328
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Optimal blood grouping and antibody screening for safe transfusion.
    Makarovska-Bojadzieva T; Blagoevska M; Kolevski P; Kostovska S
    Prilozi; 2009 Jul; 30(1):119-28. PubMed ID: 19736535
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Alloimmunity to RhD in humans.
    Urbaniak SJ
    Transfus Clin Biol; 2006; 13(1-2):19-22. PubMed ID: 16574456
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Rhesus immunization in pregnancy: a review.
    Duerbeck NB; Seeds JW
    Obstet Gynecol Surv; 1993 Dec; 48(12):801-10. PubMed ID: 8309663
    [No Abstract]   [Full Text] [Related]  

  • 34. Allo antibodies in partially silent Rh phenotypes. Evidence for a possibly new high frequency Rh antigen.
    Perrier P; Habibi B; Salmon C
    Rev Fr Transfus Immunohematol; 1980; 23(3):327-39. PubMed ID: 6773536
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antigen Nou. A new high frequency Rh antigen.
    Habibi B; Perrier P; Salmon C
    Rev Fr Transfus Immunohematol; 1981 Feb; 24(1):117-20. PubMed ID: 6784228
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Are weak D red blood cells really immunogenic?
    Schmidt PJ
    Transfusion; 2006 Nov; 46(11):2029-30. PubMed ID: 17076861
    [No Abstract]   [Full Text] [Related]  

  • 37. DAK, a new low-incidence antigen in the Rh blood group system.
    Reid ME; Storry JR; Sausais L; Tossas E; Rios M; Hue-Roye K; Gloster ES; Miller ST; Wolf C; Lomas-Francis C
    Transfusion; 2003 Oct; 43(10):1394-7. PubMed ID: 14507270
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Platelet transfusion and immunization anti-Rh1: implication for immunoprophylaxis].
    Chambost H
    Transfus Clin Biol; 2014 Nov; 21(4-5):210-5. PubMed ID: 25282489
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Serologic and molecular characterization of D variants in Brazilians: impact for typing and transfusion strategy.
    Credidio DC; Pellegrino J; Castilho L
    Immunohematology; 2011; 27(1):6-11. PubMed ID: 22356480
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Alloimmunization against platelets, granulocytes and erythrocytes in multi-transfused patients in Iranian population.
    Younesi MR; Louni Aligoudarzi S; Bigdeli R; Lashgari M; Mazaheri H; Asgary V
    Transfus Apher Sci; 2016 Oct; 55(2):205-211. PubMed ID: 27318433
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.